Comments
Roche's Avastin helps colorectal cancer patients
27.01.2012. | ZURICH (Reuters) - Patients with advanced colorectal cancer who received Roche's Avastin live longer when they also receive the drug as part of their second round of treatment, the Swiss drugmaker said on Thursday, citing a late-stage study....
